United States · Funded startup

Who invested in Cidara Therapeutics

5 rounds we have observed, with the 16 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$463Mraised across 5 rounds since 2014, from 5 sources

$30MVenture$32MSeries A$42MSeries B$20MRound$339MGrant
Latest round
Grant, $339MOct 2025
Step-upi
16.9×
Investors
16
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201420162018202020222024
$30MVenture$32MSeries A$20MRound$339MGrant
First round
Venture, $30M
Jun 2014
Biggest round
$339M
Grant · Oct 2025
Usual gap between rounds
21 months
the median of 3

The rounds

  1. Oct 2025
  2. Nov 2016
    Round$20M1 new

    Reported by FinSMEs

  3. Feb 2015
    Series B$42M7 new3 returning

    From a historical funding recordSEC filing: $42M sold, first sale Feb 2015

  4. Jun 2014
    Series A$32M4 new

    From a historical funding record

  5. Jun 2014
    Venture$30M

    No investor was named in the report.

    From a historical funding record

Founders and team

From the SEC filings it signed: 5 on the team.

  • Jeffrey SteinExecutive Officer, Directori
  • Leslie R. TariExecutive Officeri
  • Preetam R. ShahExecutive Officeri
  • Shane R. WardExecutive Officeri
  • Taylor R. SandisonExecutive Officeri

On the board, as filediBonnie R. BasslerCarin R. Canale-TheakstonDaniel D. BurgessJames R. MersonLaura R. TadvalkarRyan R. SpencerTheodore R. Schroeder

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

RA Capital ManagementPrivate equity2rounds
Perceptive AdvisorsAsset manager2rounds
5AM VenturesVC firm2rounds
Frazier Healthcare PartnersPrivate equity2rounds
Aisling CapitalPrivate equity2rounds
FidelityVC firm1round
InterWest PartnersVC firm1round
Vivo CapitalPrivate equity1round
TCGPrivate equity1round
Square 1 BankInvestment firm1round
Adage Capital ManagementAsset manager1round
TCG CrossoverVC firm1round
Rock Springs CapitalHedge fund1round
venBio PartnersVC firm1round
Sabby CapitalPrivate equity1round
Caxton Alternative Managementno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Cidara Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Frazier Life SciencesVC firmPer its own site

Quick answers about Cidara Therapeutics

Who invested in Cidara Therapeutics?

Cidara Therapeutics's investors include RA Capital Management, Perceptive Advisors, 5AM Ventures, Frazier Healthcare Partners and Aisling Capital, and 11 more on record.

How much has Cidara Therapeutics raised?

Cidara Therapeutics has raised $463M across 5 rounds since 2014.

When did Cidara Therapeutics last raise?

Cidara Therapeutics's most recent round was a Grant of $339M in Oct 2025.

What was Cidara Therapeutics's biggest round?

Its most recent round, $339M in Oct 2025, is also its largest on record.

Who backed Cidara Therapeutics first?

Cidara Therapeutics's first round on record, in Jun 2014, was backed by InterWest Partners, 5AM Ventures and Frazier Healthcare Partners and 1 others.

What stage is Cidara Therapeutics at?

Cidara Therapeutics's latest named round is a Grant, in Oct 2025.

Where is Cidara Therapeutics based?

Cidara Therapeutics is based in the United States.

Companies like Cidara Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.